Trial Profile
Decitibine combined with activated DLI for acute myeloid leukemia patients with hematologic relapse after allogeneic hematopoietic stem cell transplantation: a single arm prospective clinical trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2016
Price :
$35
*
At a glance
- Drugs Decitabine (Primary) ; Interferon alpha-2b (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 27 Apr 2016 New trial record